Molecular mechanisms of regulatory T cell development and suppressive function

Progress in Molecular Biology and Translational Science

Volumn 92, Issue C, 2010, Pages 279-314

  Kim, Jeong M ^a  

^a GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FORKHEAD TRANSCRIPTION FACTOR;

ANIMAL; ANTIGEN PRESENTING CELL; ARTICLE; CELL DIFFERENTIATION; CYTOLOGY; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; METABOLISM; REGULATORY T LYMPHOCYTE;

ANIMALS; ANTIGEN-PRESENTING CELLS; CELL DIFFERENTIATION; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNE TOLERANCE; T-LYMPHOCYTES, REGULATORY;

EID: 77958118358     PISSN: 18771173     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1877-1173(10)92011-5     Document Type: Chapter

References (156)

1. S. Sakaguchi, N. Sakaguchi, M. Asano, M. Itoh, and M. Toda Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases J Immunol 155 1995 1151 1164
2. Q. Tang, K.J. Henriksen, M. Bi, E.B. Finger, G. Szot, and J. Ye In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes J Exp Med 199 2004 1455 1465
3. + regulatory T cells J Immunol 170 2003 3939 3943
4. + regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis J Immunol 169 2002 4712 4716
5. K.J. Scalapino, Q. Tang, J.A. Bluestone, M.L. Bonyhadi, and D.I. Daikh Suppression of disease in New Zealand Black/New Zealand White lupus-prone mice by adoptive transfer of ex vivo expanded regulatory T cells J Immunol 177 2006 1451 1459
6. T. Yanagawa, Y. Hidaka, V. Guimaraes, M. Soliman, and L.J. DeGroot CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian population J Clin Endocrinol Metab 80 1995 41 45
7. S.F. Atabani, C.L. Thio, S. Divanovic, A. Trompette, Y. Belkaid, and D.L. Thomas Association of CTLA4 polymorphism with regulatory T cell frequency Eur J Immunol 35 2005 2157 2162
8. L. Nistico, R. Buzzetti, L.E. Pritchard, B. Van der Auwera, C. Giovannini, and E. Bosi The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry Hum Mol Genet 5 1996 1075 1080
9. A. Vella, J.D. Cooper, C.E. Lowe, N. Walker, S. Nutland, and B. Widmer Localization of a type 1 diabetes locus in the IL2RA/CD25 region by use of tag single-nucleotide polymorphisms Am J Hum Genet 76 2005 773 779
10. C.L. Bennett, J. Christie, F. Ramsdell, M.E. Brunkow, P.J. Ferguson, and L. Whitesell The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3 Nat Genet 27 2001 20 21
11. T.A. Chatila, F. Blaeser, N. Ho, H.M. Lederman, C. Voulgaropoulos, and C. Helms JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome J Clin Invest 106 2000 R75 R81
12. R.S. Wildin, F. Ramsdell, J. Peake, F. Faravelli, J.L. Casanova, and N. Buist X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy Nat Genet 27 2001 18 20
13. M.E. Brunkow, E.W. Jeffery, K.A. Hjerrild, B. Paeper, and L.B. Clark Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse Nat Genet 27 2001 68 73
14. J.D. Fontenot, J.L. Dooley, A.G. Farr, and A.Y. Rudensky Developmental regulation of Foxp3 expression during ontogeny J Exp Med 202 2005 901 906
15. S. Hori, T. Nomura, and S. Sakaguchi Control of regulatory T cell development by the transcription factor Foxp3 Science 299 2003 1057 1061
16. + T regulatory cells Nat Immunol 4 2003 337 342
17. + regulatory T cells Nat Immunol 4 2003 330 336
18. J.D. Fontenot Regulatory T cell lineage specification by the forkhead transcription factor foxp3 Immunity 22 2005 329 341
19. + subset J Immunol 183 2009 2261 2266
20. + regulatory T cells in human thymus Nature 436 2005 1181 1185
21. + immunoregulatory T cells that control autoimmune diabetes Immunity 12 2000 431 440
22. X. Tai, M. Cowan, L. Feigenbaum, and A. Singer CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2 Nat Immunol 6 2005 152 162
23. S.J. Bensinger, A. Bandeira, M.S. Jordan, A.J. Caton, and T.M. Laufer Major histocompatibility complex class II-positive cortical epithelium mediates the selection of CD4(+)25(+) immunoregulatory T cells J Exp Med 194 2001 427 438
24. A. Liston, K.M. Nutsch, A.G. Farr, J.M. Lund, J.P. Rasmussen, and P.A. Koni Differentiation of regulatory Foxp3+ T cells in the thymic cortex Proc Natl Acad Sci USA 105 2008 11903 11908
25. I. Apostolou, A. Sarukhan, L. Klein, and H. von Boehmer Origin of regulatory T cells with known specificity for antigen Nat Immunol 3 2002 756 763
26. A.J. Caton, C. Cozzo, J. Larkin 3rd, M.A. Lerman, A. Boesteanu, and M.S. Jordan CD4(+) CD25(+) regulatory T cell selection Ann NY Acad Sci 1029 2004 101 114
27. + regulatory T cells induced by an agonist self-peptide Nat Immunol 2 2001 301 306
28. K. Kawahata, Y. Misaki, M. Yamauchi, S. Tsunekawa, K. Setoguchi, and J. Miyazaki Generation of CD4(+)CD25(+) regulatory T cells from autoreactive T cells simultaneously with their negative selection in the thymus and from nonautoreactive T cells by endogenous TCR expression J Immunol 168 2002 4399 4405
29. + regulatory T cells in vivo J Exp Med 198 2003 249 258
30. H.M. van Santen, C. Benoist, and D. Mathis Number of T reg cells that differentiate does not increase upon encounter of agonist ligand on thymic epithelial cells J Exp Med 200 2004 1221 1230
31. C.W. Lio, and C.S. Hsieh A two-step process for thymic regulatory T cell development Immunity 28 2008 100 111
32. J.D. Fontenot, J.P. Rasmussen, M.A. Gavin, and A.Y. Rudensky A function for interleukin 2 in Foxp3-expressing regulatory T cells Nat Immunol 6 2005 1142 1151
33. T.R. Malek, A. Yu, V. Vincek, P. Scibelli, and L. Kong CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2 Immunity 17 2002 167 178
34. + regulatory T cells J Immunol 178 2007 280 290
35. A. Marson, K. Kretschmer, G.M. Frampton, E.S. Jacobsen, J.K. Polansky, and K.D. MacIsaac Foxp3 occupancy and regulation of key target genes during T-cell stimulation Nature 445 2007 931 935
36. Y. Zheng, S.Z. Josefowicz, A. Kas, T.T. Chu, M.A. Gavin, and A.Y. Rudensky Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells Nature 445 2007 936 940
37. M.A. Gavin, J.P. Rasmussen, J.D. Fontenot, V. Vasta, V.C. Manganiello, and J.A. Beavo Foxp3-dependent programme of regulatory T-cell differentiation Nature 445 2007 771 775
38. J.A. Hill, M. Feuerer, K. Tash, S. Haxhinasto, J. Perez, and R. Melamed Foxp3 transcription-factor-dependent and -independent regulation of the regulatory T cell transcriptional signature Immunity 27 2007 786 800
39. W. Lin, D. Haribhai, L.M. Relland, N. Truong, M.R. Carlson, and C.B. Williams Regulatory T cell development in the absence of functional Foxp3 Nat Immunol 8 2007 359 368
40. M. Ono, M. Borde, V. Heissmeyer, M. Feuerer, A.D. Lapan, and J.C. Stroud Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1 Nature 446 2007 685 689
41. Y. Wu, M. Borde, V. Heissmeyer, M. Feuerer, A.D. Lapan, and J.C. Stroud FOXP3 controls regulatory T cell function through cooperation with NFAT Cell 126 2006 375 387
42. L. Zhou, J.E. Lopes, M.M. Chong, II Ivanov, R. Min, and G.D. Victora TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function Nature 453 2008 236 240
43. + regulatory T cells Science 325 2009 1142 1146
44. + regulatory T cells by TGF-beta induction of transcription factor Foxp3 J Exp Med 198 2003 1875 1886
45. Y.Y. Wan, and R.A. Flavell Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter Proc Natl Acad Sci USA 102 2005 5126 5131
46. - precursors Am J Transplant 4 2004 1614 1627
47. K. Kretschmer, I. Apostolou, D. Hawiger, K. Khazaie, M.C. Nussenzweig, and H. von Boehmer Inducing and expanding regulatory T cell populations by foreign antigen Nat Immunol 6 2005 1219 1227
48. Y. Tone, K. Furuuchi, Y. Kojima, M.L. Tykocinski, M.I. Greene, and M. Tone Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer Nat Immunol 9 2008 194 202
49. I. Apostolou, and H. von Boehmer In vivo instruction of suppressor commitment in naive T cells J Exp Med 199 2004 1401 1408
50. + CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen J Immunol 167 2001 188 195
51. M.J. Benson, K. Pino-Lagos, M. Rosemblatt, and R.J. Noelle All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation J Exp Med 204 2007 1765 1774
52. J.M. Kim, and A. Rudensky The role of the transcription factor Foxp3 in the development of regulatory T cells Immunol Rev 212 2006 86 98
53. E.A. Wohlfert, L. Gorelik, R. Mittler, R.A. Flavell, and R.B. Clark Cutting edge: deficiency in the E3 ubiquitin ligase Cbl-b results in a multifunctional defect in T cell TGF-beta sensitivity in vitro and in vivo J Immunol 176 2006 1316 1320
54. + regulatory cells J Immunol 176 2006 3321 3329
55. + regulatory T cells Proc Natl Acad Sci USA 104 2007 18169 18174
56. S. Sad, and T.R. Mosmann Single IL-2-secreting precursor CD4 T cell can develop into either Th1 or Th2 cytokine secretion phenotype J Immunol 153 1994 3514 3522
57. S.L. Swain, G. Huston, S. Tonkonogy, and A. Weinberg Transforming growth factor-beta and IL-4 cause helper T cell precursors to develop into distinct effector helper cells that differ in lymphokine secretion pattern and cell surface phenotype J Immunol 147 1991 2991 3000
58. V.L. Heath, E.E. Murphy, C. Crain, M.G. Tomlinson, and A. O'Garra TGF-beta1 down-regulates Th2 development and results in decreased IL-4-induced STAT6 activation and GATA-3 expression Eur J Immunol 30 2000 2639 2649
59. L. Gorelik, S. Constant, and R.A. Flavell Mechanism of transforming growth factor beta-induced inhibition of T helper type 1 differentiation J Exp Med 195 2002 1499 1505
60. L. Gorelik, P.E. Fields, and R.A. Flavell Cutting edge: TGF-beta inhibits Th type 2 development through inhibition of GATA-3 expression J Immunol 165 2000 4773 4777
61. C.M. Sun, J.A. Hall, R.B. Blank, N. Bouladoux, M. Oukka, and J.R. Mora Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid J Exp Med 204 2007 1775 1785
62. J.L. Coombes, K.R. Siddiqui, C.V. Arancibia-Carcamo, J. Hall, C.M. Sun, and Y. Belkaid A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism J Exp Med 204 2007 1757 1764
63. + CD44hi Cells Immunity 29 2008 758 770
64. D. Mucida, K. Pino-Lagos, G. Kim, E. Nowak, M.J. Benson, and M. Kronenberg Retinoic acid can directly promote TGF-beta-mediated Foxp3(+) Treg cell conversion of naive T cells Immunity 30 2009 471 472 author reply 472473
65. H.P. Kim, and W.J. Leonard CREB/ATF-dependent T cell receptor-induced FoxP3 gene expression: a role for DNA methylation J Exp Med 204 2007 1543 1551
66. P.Y. Mantel Molecular mechanisms underlying FOXP3 induction in human T cells J Immunol 176 2006 3593 3602
67. Q. Ruan, V. Kameswaran, Y. Tone, L. Li, H.C. Liou, and M.I. Greene Development of Foxp3(+) regulatory t cells is driven by the c-Rel enhanceosome Immunity 31 2009 932 940
68. + regulatory T cell development J Exp Med 203 2006 119 129
69. M. Oh-Hora, M. Yamashita, P.G. Hogan, S. Sharma, E. Lamperti, and W. Chung Dual functions for the endoplasmic reticulum calcium sensors STIM1 and STIM2 in T cell activation and tolerance Nat Immunol 9 2008 432 443
70. S. Sakaguchi, and N. Sakaguchi Thymus and autoimmunity. Transplantation of the thymus from cyclosporin A-treated mice causes organ-specific autoimmune disease in athymic nude mice J Exp Med 167 1988 1479 1485
71. S. Sakaguchi, and N. Sakaguchi Organ-specific autoimmune disease induced in mice by elimination of T cell subsets. V. Neonatal administration of cyclosporin A causes autoimmune disease J Immunol 142 1989 471 480
72. N. Muthusamy, and J.M. Leiden A protein kinase C-, Ras-, and RSK2-dependent signal transduction pathway activates the cAMP-responsive element-binding protein transcription factor following T cell receptor engagement J Biol Chem 273 1998 22841 22847
73. + regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo Blood 108 2006 1571 1579
74. S.Z. Josefowicz, C.B. Wilson, and A.Y. Rudensky Cutting edge: TCR stimulation is sufficient for induction of Foxp3 expression in the absence of DNA methyltransferase 1 J Immunol 182 2009 6648 6652
75. + regulatory T cells Immunity 31 2009 609 620
76. D. Rudra, T. Egawa, M.M. Chong, P. Treuting, D.R. Littman, and A.Y. Rudensky Runx-CBFbeta complexes control expression of the transcription factor Foxp3 in regulatory T cells Nat Immunol 10 2009 1170 1177
77. L. Bruno, L. Mazzarella, M. Hoogenkamp, A. Hertweck, B.S. Cobb, and S. Sauer Runx proteins regulate Foxp3 expression J Exp Med 206 2009 2329 2337
78. + inducible regulatory T cells J Exp Med 206 2009 2701 2715
79. + regulatory and natural killer-like T cells on signals leading to NF-kappaB activation Proc Natl Acad Sci USA 101 2004 4566 4571
80. Y.Y. Wan, H. Chi, M. Xie, M.D. Schneider, and R.A. Flavell The kinase TAK1 integrates antigen and cytokine receptor signaling for T cell development, survival and function Nat Immunol 7 2006 851 858
81. M. Long, S.G. Park, I. Strickland, M.S. Hayden, and S. Ghosh Nuclear factor-kappaB modulates regulatory T cell development by directly regulating expression of Foxp3 transcription factor Immunity 31 2009 921 931
82. + regulatory T cells Nat Immunol 9 2008 632 640
83. + regulatory T cells in the absence of interleukin 2 signaling Nat Immunol 6 2005 1152 1159
84. A. Liston, O.M. Siggs, and C.C. Goodnow Tracing the action of IL-2 in tolerance to islet-specific antigen Immunol Cell Biol 85 2007 338 342
85. + T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells J Immunol 160 1998 1212 1218
86. + CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state Int Immunol 10 1998 1969 1980
87. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production J Exp Med 188 1998 287 296
88. + T regulatory cell-mediated suppression Immunity 30 2009 636 645
89. + T cells and dendritic cells in vivo J Exp Med 203 2006 505 511
90. Q. Tang, J.Y. Adams, A.J. Tooley, M. Bi, B.T. Fife, and P. Serra Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice Nat Immunol 7 2006 83 92
91. + regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells Eur J Immunol 30 2000 1538 1543
92. + CD25high regulatory T cells modulate myeloid but not plasmacytoid dendritic cells activation J Immunol 176 2006 5293 5298
93. + T cells restrain the maturation and antigen-presenting function of dendritic cells J Immunol 172 2004 4676 4680
94. M. Veldhoen, H. Moncrieffe, R.J. Hocking, C.J. Atkins, and B. Stockinger Modulation of dendritic cell function by naive and regulatory CD4+ T cells J Immunol 176 2006 6202 6210
95. J.M. Kim, J.P. Rasmussen, and A.Y. Rudensky Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice Nat Immunol 8 2007 191 197
96. K. Liu, G.D. Victora, T.A. Schwickert, P. Guermonprez, M.M. Meredith, and K. Yao In vivo analysis of dendritic cell development and homeostasis Science 324 2009 392 397
97. + immunoregulatory cells J Immunol 167 2001 1137 1140
98. + CD4+ T cells: a common basis between tumor immunity and autoimmunity J Immunol 163 1999 5211 5218
99. S. Onizuka, I. Tawara, J. Shimizu, S. Sakaguchi, T. Fujita, and E. Nakayama Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody Cancer Res 59 1999 3128 3133
100. + regulatory cells augments the generation of specific immune T cells in tumor-draining lymph nodes J Immunother 25 2002 207 217
101. T.R. Mempel, M.J. Pittet, K. Khazaie, W. Weninger, R. Weissleder, and H. von Boehmer Regulatory T cells reversibly suppress cytotoxic T cell function independent of effector differentiation Immunity 25 2006 129 141
102. M.L. Chen, M.J. Pittet, L. Gorelik, R.A. Flavell, R. Weissleder, and H. von Boehmer Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo Proc Natl Acad Sci USA 102 2005 419 424
103. B. Pasche Role of transforming growth factor beta in cancer J Cell Physiol 186 2001 153 168
104. + T cell responses J Exp Med 198 2003 889 901
105. + T cell responses J Exp Med 196 2002 1585 1592
106. + T cells Proc Natl Acad Sci USA 99 2002 8832 8837
107. A.M. Wolf, D. Wolf, M. Steurer, G. Gastl, E. Gunsilius, and B. Grubeck-Loebenstein Increase of regulatory T cells in the peripheral blood of cancer patients Clin Cancer Res 9 2003 606 612
108. + regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner J Exp Med 202 2005 1075 1085
109. + T regulatory cells inhibit cytotoxic activity of CTL and NK cells in humans-impact of immunosenescence Clin Immunol 119 2006 307 316
110. + T regulatory cells suppress NK cell-mediated immunotherapy of cancer J Immunol 176 2006 1582 1587
111. L.B. Clark, M.W. Appleby, M.E. Brunkow, J.E. Wilkinson, S.F. Ziegler, and F. Ramsdell Cellular and molecular characterization of the scurfy mouse mutant J Immunol 162 1999 2546 2554
112. + regulatory T cells J Immunol 175 2005 4180 4183
113. R.S. Bystry, V. Aluvihare, K.A. Welch, M. Kallikourdis, and A.G. Betz B cells and professional APCs recruit regulatory T cells via CCL4 Nat Immunol 2 2001 1126 1132
114. + T cells selectively kill B lymphocytes Blood 107 2006 3925 3932
115. L. Gorelik, and R.A. Flavell Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease Immunity 12 2000 171 181
116. M.O. Li, Y.Y. Wan, and R.A. Flavell T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation Immunity 26 2007 579 591
117. K. Nakamura, A. Kitani, and W. Strober Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta J Exp Med 194 2001 629 644
118. C.A. Piccirillo, J.J. Letterio, A.M. Thornton, R.S. McHugh, M. Mamura, and H. Mizuhara CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness J Exp Med 196 2002 237 246
119. R. Kuhn, J. Lohler, D. Rennick, K. Rajewsky, and W. Muller Interleukin-10-deficient mice develop chronic enterocolitis Cell 75 1993 263 274
120. A. Roers, L. Siewe, E. Strittmatter, M. Deckert, D. Schluter, and W. Stenzel T cell-specific inactivation of the interleukin 10 gene in mice results in enhanced T cell responses but normal innate responses to lipopolysaccharide or skin irritation J Exp Med 200 2004 1289 1297
121. Y.P. Rubtsov, J.P. Rasmussen, E.Y. Chi, J. Fontenot, L. Castelli, and X. Ye Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces Immunity 28 2008 546 558
122. C. Asseman, S. Mauze, M.W. Leach, R.L. Coffman, and F. Powrie An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation J Exp Med 190 1999 995 1004
123. A. Hagenbaugh, S. Sharma, S.M. Dubinett, S.H. Wei, R. Aranda, and H. Cheroutre Altered immune responses in interleukin 10 transgenic mice J Exp Med 185 1997 2101 2110
124. + regulatory T cells is interleukin 10 dependent J Exp Med 202 2005 1539 1547
125. I. Kryczek, S. Wei, L. Zou, G. Zhu, P. Mottram, and H. Xu Cutting edge: induction of B7-H4 on APCs through IL-10: novel suppressive mode for regulatory T cells J Immunol 177 2006 40 44
126. M.F. Bachmann, G. Kohler, B. Ecabert, T.W. Mak, and M. Kopf Cutting edge: lymphoproliferative disease in the absence of CTLA-4 is not T cell autonomous J Immunol 163 1999 1128 1131
127. S. Read, V. Malmstrom, and F. Powrie Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation J Exp Med 192 2000 295 302
128. T. Takahashi, T. Tagami, S. Yamazaki, T. Uede, J. Shimizu, and N. Sakaguchi Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4 J Exp Med 192 2000 303 310
129. P.S. Linsley, W. Brady, M. Urnes, L.S. Grosmaire, N.K. Damle, and J.A. Ledbetter CTLA-4 is a second receptor for the B cell activation antigen B7 J Exp Med 174 1991 561 569
130. R.J. Peach, J. Bajorath, W. Brady, G. Leytze, J. Greene, and J. Naemura Complementarity determining region 1 (CDR1)- and CDR3-analogous regions in CTLA-4 and CD28 determine the binding to B7-1 J Exp Med 180 1994 2049 2058
131. T.L. Walunas, C.Y. Bakker, and J.A. Bluestone CTLA-4 ligation blocks CD28-dependent T cell activation J Exp Med 183 1996 2541 2550
132. E.A. Tivol, S.D. Boyd, S. McKeon, F. Borriello, P. Nickerson, and T.B. Strom CTLA4Ig prevents lymphoproliferation and fatal multiorgan tissue destruction in CTLA-4-deficient mice J Immunol 158 1997 5091 5094
133. C.B. Thompson, and J.P. Allison The emerging role of CTLA-4 as an immune attenuator Immunity 7 1997 445 450
134. F. Fallarino, U. Grohmann, K.W. Hwang, C. Orabona, C. Vacca, and R. Bianchi Modulation of tryptophan catabolism by regulatory T cells Nat Immunol 4 2003 1206 1212
135. U. Grohmann, C. Orabona, F. Fallarino, C. Vacca, F. Calcinaro, and A. Falorni CTLA-4-Ig regulates tryptophan catabolism in vivo Nat Immunol 3 2002 1097 1101
136. P. Hwu, M.X. Du, R. Lapointe, M. Do, M.W. Taylor, and H.A. Young Indoleamine 2, 3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation J Immunol 164 2000 3596 3599
137. D.H. Munn, E. Shafizadeh, J.T. Attwood, I. Bondarev, A. Pashine, and A.L. Mellor Inhibition of T cell proliferation by macrophage tryptophan catabolism J Exp Med 189 1999 1363 1372
138. C. Orabona, U. Grohmann, M.L. Belladonna, F. Fallarino, C. Vacca, and R. Bianchi CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86 Nat Immunol 5 2004 1134 1142
139. + T cell-mediated suppression by dendritic cells Science 299 2003 1033 1036
140. + natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation Proc Natl Acad Sci USA 105 2008 10113 10118
141. + regulatory T cell function Science 322 2008 271 275
142. M. Azuma, H. Yssel, J.H. Phillips, H. Spits, and L.L. Lanier Functional expression of B7/BB1 on activated T lymphocytes J Exp Med 177 1993 845 850
143. D.M. Sansom, and N.D. Hall B7/BB1, the ligand for CD28, is expressed on repeatedly activated human T cells in vitro Eur J Immunol 23 1993 295 298
144. P.A. Taylor, C.J. Lees, S. Fournier, J.P. Allison, A.H. Sharpe, and B.R. Blazar B7 expression on T cells down-regulates immune responses through CTLA-4 ligation via T-T interactions [corrections] J Immunol 172 2004 34 39
145. S. Paust, L. Lu, N. McCarty, and H. Cantor Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease Proc Natl Acad Sci USA 101 2004 10398 10403
146. S. Marazzi, S. Blum, R. Hartmann, D. Gundersen, M. Schreyer, and S. Argraves Characterization of human fibroleukin, a fibrinogen-like protein secreted by T lymphocytes J Immunol 161 1998 138 147
147. + T reg cells impinge on autoimmune diabetes J Exp Med 202 2005 1387 1397
148. C.W. Chan Soluble fibrinogen-like protein 2/fibroleukin exhibits immunosuppressive properties: suppressing T cell proliferation and inhibiting maturation of bone marrow-derived dendritic cells J Immunol 170 2003 4036 4044
149. I. Shalev, H. Liu, C. Koscik, A. Bartczak, M. Javadi, and K.M. Wong Targeted deletion of fgl2 leads to impaired regulatory T cell activity and development of autoimmune glomerulonephritis J Immunol 180 2008 249 260
150. + regulatory cells involves a granzyme B-dependent, perforin-independent mechanism J Immunol 174 2005 1783 1786
151. W.J. Grossman, J.W. Verbsky, W. Barchet, M. Colonna, J.P. Atkinson, and T.J. Ley Human T regulatory cells can use the perforin pathway to cause autologous target cell death Immunity 21 2004 589 601
152. K.A. Browne, E. Blink, V.R. Sutton, C.J. Froelich, D.A. Jans, and J.A. Trapani Cytosolic delivery of granzyme B by bacterial toxins: evidence that endosomal disruption, in addition to transmembrane pore formation, is an important function of perforin Mol Cell Biol 19 1999 8604 8615
153. S. Deaglio, K.M. Dwyer, W. Gao, D. Friedman, A. Usheva, and A. Erat Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression J Exp Med 204 2007 1257 1265
154. J.J. Kobie, P.R. Shah, L. Yang, J.A. Rebhahn, D.J. Fowell, and T.R. Mosmann T regulatory and primed uncommitted CD4 T cells express CD73, which suppresses effector CD4 T cells by converting 5′-adenosine monophosphate to adenosine J Immunol 177 2006 6780 6786
155. T. Kambayashi, R.P. Wallin, and H.G. Ljunggren cAMP-elevating agents suppress dendritic cell function J Leukoc Biol 70 2001 903 910
156. E. Panther, M. Idzko, Y. Herouy, H. Rheinen, P.J. Gebicke-Haerter, and U. Mrowietz Expression and function of adenosine receptors in human dendritic cells FASEB J 15 2001 1963 1970